Changes in PDA treatment strategy and respiratory outcomes: Optimal timing of intervention … continuing the long conversation
- PMID: 34251054
- DOI: 10.1111/apa.16006
Changes in PDA treatment strategy and respiratory outcomes: Optimal timing of intervention … continuing the long conversation
Comment on
-
Changes in Patent Ductus Arteriosus Treatment Strategy and Respiratory Outcomes in Premature Infants.J Pediatr. 2021 Aug;235:58-62. doi: 10.1016/j.jpeds.2021.04.030. Epub 2021 Apr 21. J Pediatr. 2021. PMID: 33894266
References
REFERENCES
-
- Chess PR, D'Angio CT, Pryhuber GS, Maniscalco WM. Pathogenesis of bronchopulmonary dysplasia. Semin Perinatol. 2006;30(4):171-178.
-
- Benitz WE. Patent ductus arteriosus in preterm infants. Pediatrics. 2016;137(1):e20153730.
-
- Mailaparambil B, Krueger M, Heizmann U, Schlegel K, Heinze J, Heinzmann A. Genetic and epidemiological risk factors in the development of bronchopulmonary dysplasia. Dis Markers. 2010;29(1):1-9.
-
- Philip R, Waller BR, Chilakala S, et al. Hemodynamic and clinical consequences of early versus delayed closure of patent ductus arteriosus in extremely low birth weight infants. J Perinatol. 2021;41(1):100-108.
-
- Ibrahim T, Haium AAA, Tapawan SJ, et al. Selective treatment of PDA in high-risk VLBW infants with birth weight ≤800 g or <27 weeks and short-term outcome: a cohort study. Front Pediatr. 2020;8:607772.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
